Celularity (CELUW) EBT Margin (2020 - 2025)

Celularity (CELUW) reported EBT Margin of 593.54% for Q4 2025, up 133858.0% year-over-year from N/an in Q4 2024, and down 35.91% quarter-over-quarter from 436.71% in Q3 2025.

Celularity (CELUW) EBT Margin (2020 - 2025) Analysis & Trends

Celularity (CELUW) has 6 years of EBT Margin data on file, last reported at 593.54% in Q4 2025.

  • EBT Margin for Q4 2025 came in at 593.54%, up 133858.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 345.44% (down 18802.0% YoY), and the FY2025 annual result was 345.44%, down 23866.0% from the prior year.
  • EBT Margin fell to 593.54% in Q4 2025 per CELUW's latest filing, from 436.71% in the prior quarter.
  • Over five years, EBT Margin peaked at 1267.03% in Q2 2022 and troughed at 3065.38% in Q1 2021.
  • A 5-year average of 668.92% and a median of 300.36% in 2024 frame the typical range for EBT Margin.
  • The sharpest annual moves came in 2022 and 2023: EBT Margin surged 328383 bps in 2022, then tumbled 289906 bps in 2023.
  • A 5-year view of EBT Margin shows it stood at 82.78% in 2021, then soared by 815 bps to 592.08% in 2022, then slumped by 87 bps to 78.91% in 2023, then slumped by 2549 bps to 1932.12% in 2024, then surged by 69 bps to 593.54% in 2025.
  • Business Quant data shows CELUW's EBT Margin at 593.54% in Q4 2025, 436.71% in Q3 2025, and 427.55% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 6.40%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 41.95%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Celularity - - -3.27 Mn -593.54%

Historic Data

Download Data
DateValue
Dec 31, 2025 -593.54%
Sep 30, 2025 -436.71%
Jun 30, 2025 -427.55%
Mar 31, 2025 -172.89%
Dec 31, 2024 -1,932.12%
Sep 30, 2024 -173.17%
Jun 30, 2024 -53.57%
Mar 31, 2024 -149.94%
Dec 31, 2023 78.91%
Sep 30, 2023 -2,479.56%
Jun 30, 2023 -1,632.03%
Mar 31, 2023 -1,626.86%
Dec 31, 2022 592.08%
Sep 30, 2022 115.65%
Jun 30, 2022 1,267.03%
Mar 31, 2022 -1,059.26%
Dec 31, 2021 -82.78%
Sep 30, 2021 470.14%
Jun 30, 2021 -2,016.80%
Mar 31, 2021 -3,065.38%